Literature DB >> 8726303

Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists.

B Moum1, M H Vatn, A Ekbom, E Aadland, O Fausa, I Lygren, N Stray, J Sauar, T Schulz.   

Abstract

BACKGROUND: Standardized criteria for Crohn's disease (CD) have only recently been developed, and prospective community-based incidence studies have been performed only during the past 3 decades. Geographic variations in incidence may therefore be due to differences in study design.
METHODS: From 1 January 1990 to 31 December 1993 all new cases of CD in four counties in southeastern Norway were prospectively registered.
RESULTS: A total of 225 new cases yielded an annual incidence of 5.8/10(5), with the highest incidence in mixed rural-urban areas. A peak of 11.2/10(5) in the annual incidence was found for the age group 15 to 24 years, with no significant differences in the overall annual incidence by gender. An average duration of 6 months of disease before diagnosis was unchanged during the 4 years. About half of the patients had isolated colonic disease, and one-quarter had isolated small-bowel disease.
CONCLUSIONS: This study confirms the high incidence figures for Scandinavia, with a particularly high incidence in mixed rural-urban areas. Ileocolonoscopy improves the accuracy of the diagnosis and of the determination of disease extent, which may have therapeutic implications for the treatment and follow-up of patients.

Entities:  

Mesh:

Year:  1996        PMID: 8726303     DOI: 10.3109/00365529609006410

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  25 in total

1.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

2.  Crohn's disease diagnosis following discovery of in situ follicular lymphoma.

Authors:  Chad L McDonald; Pablo J Calzada
Journal:  Gastrointest Cancer Res       Date:  2011-09

Review 3.  Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing?

Authors:  Cristina Saro Gismera; Beatriz Sicilia Aladrén
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

Review 4.  Methodology for high-quality studies on course and prognosis of inflammatory bowel disease.

Authors:  Irene Modesto; Giovanni Perricone; Ambrogio Orlando; Mario Cottone
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

5.  Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa).

Authors:  Thea Myklebust-Hansen; Geir Aamodt; Margaretha Haugen; Anne Lise Brantsæter; Morten H Vatn; May-Bente Bengtson
Journal:  Inflamm Bowel Dis       Date:  2017-12-19       Impact factor: 5.325

6.  Enterotachogram analysis to distinguish irritable bowel syndrome from Crohn's disease.

Authors:  B L Craine; M L Silpa; C J O'Toole
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

Review 7.  Epidemiology and clinical course of Crohn's disease: results from observational studies.

Authors:  Øistein Hovde; Bjørn A Moum
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

8.  Crohn's disease incidence evolution in North-western Greece is not associated with alteration of NOD2/CARD15 variants.

Authors:  Michael Economou; Grigoris Filis; Zoi Tsianou; John Alamanos; Antonios Kogevinas; Kostas Masalas; Anna Petrou; Epameinondas V Tsianos
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

9.  Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999).

Authors:  F Molinié; C Gower-Rousseau; T Yzet; V Merle; B Grandbastien; R Marti; E Lerebours; J-L Dupas; J-F Colombel; J-L Salomez; A Cortot
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

10.  Lymphadenopathy in an oriental with ankylosing spondylitis.

Authors:  L B Liou; T C Chen
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.